Pomdoctor POM

POMDOCTOR Ltd is a leading online medical services platform focused on chronic disease management in China. The company was founded to provide continuous care for patients with long term illnesses and to create a reliable connection between patients and physicians. Its platform combines an Internet hospital that offers remote consultation and prescription renewal with a pharmaceutical supply chain that stores and distributes medicines. POMDOCTOR Ltd operates through a mobile application and a WeChat official account, enabling users to access medical services anytime and anywhere. As of June 30 2024 the platform had over 212 000 contracted doctors and approximately 683 000 transacting patients. The company’s mission centers on alleviating patient suffering through effective prevention and treatment solutions while its vision aims to become the most trustworthy medical and healthcare services platform in the country.

POMDOCTOR Ltd generates revenue from several interconnected sources. It charges fees for online consultation services provided by its network of doctors. It also earns income from prescription renewal transactions where patients obtain medication through the platform. The pharmaceutical supply chain contributes revenue by selling drugs to third party pharmacies online drug retailers and wholesale distributors. Additionally the company receives fees for supplying logistics warehousing and inventory management services to external partners. In 2023 the average revenue per paying patient reached RMB714 and rose to RMB733 in the first six months of 2024 reflecting the growing value of its services. The company does not rely on advertising campaigns for its primary income stream.

The company operates through the following segments:

• Internet Hospital: This segment provides remote medical consultations prescription renewals and chronic disease management programs. Patients connect with contracted doctors through a mobile app or WeChat official account using text images or voice communication. Doctors can issue prescriptions after reviewing patient information and the platform supports follow up visits without requiring physical hospital attendance. The segment also offers tools for patient grouping medical record access and medication reminders to improve treatment continuity.
• Pharmaceutical Supply Chain: This segment handles the procurement storage and distribution of pharmaceutical products. It maintains a broad catalogue of over 40 000 SKUs including prescription and non prescription medicines. The company sources drugs from a network of suppliers and operates warehouses that support timely delivery to pharmacies hospitals and individual patients. Services include inventory management order processing logistics coordination and quality control to ensure medicine safety and availability.

POMDOCTOR Ltd holds a strong competitive position within China’s rapidly expanding digital healthcare sector. According to Frost & Sullivan the company ranked sixth among Internet hospitals by number of contracted doctors in 2022. The platform benefits from a large and stable physician base with retention rates for mature doctors exceeding 99 percent in recent years. Its advantages include an integrated model that links consultation services with a reliable drug supply chain advanced technology infrastructure supported by numerous patents and software copyrights and a proven ability to foster long term patient doctor relationships. Key competitors in the Internet hospital market include Medlinker Hao Daifu and Ping An Good Doctor but POMDOCTOR Ltd differentiates itself through its focus on chronic disease follow up care and its extensive network of contracted physicians across all provinces.

The company’s customer base consists primarily of individuals living with chronic diseases who require regular medical follow up and medication refills. These patients use the platform to consult their original attending physicians and to obtain prescription renewals without traveling to hospitals. Physicians constitute another major group of users who rely on the platform for patient management prescription issuance and access to medical tools. In addition POMDOCTOR Ltd serves pharmaceutical companies pharmacies and online drug retailers that purchase medicines through its supply chain channel. As of June 30 2024 the platform had 85 229 doctors issuing prescriptions and served approximately 683 000 transacting patients reflecting a broad and engaged user community across China.